£399k
vs Jun 2024Active13135667Private limited companyCambridge
CAMBRIDGE NUCLEOMICS LTD
Significant control: Hendrik Friedrich Peter Runge (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cambridge Nucleomics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Cambridge Nucleomics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CAMBRIDGE NUCLEOMICS LTD is an active private limited company (company number 13135667) incorporated on 15 January 2021, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of £399k and cash of £528k, with 2 employees on average. Net assets rose 472% on the prior period (−£107k).
Peer position · net assets
By net assets it sits in the top quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Mr Hendrik Friedrich Peter Runge
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Max Zhu
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr. Ulrich Felix Keyser
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 15 January 20215 yrs ago
- Next accounts due
- 30 March 2027in 157 days
- Confirmation statement due
- 29 January 2027in 97 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£528k
+4979%vs Jun 2024Not reported
2
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £399k | £528k | £21k | — | — | — | 2 |
| 30 June 2024 | −£107k | £10k | £25k | — | — | — | 2 |
Cash per employee£264kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £399,086 at 30 June 2025
- Net assets up 10% or more on the prior period+471.9% vs prior period
- Cash at bank of £50,000 or moreCash £527,579
- Incorporated five or more years agoIncorporated 15 January 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 157 days
- Confirmation statement duein 97 days
- Accounts period endNet assets £399k · small accounts
- Accounts period endNet liabilities £107k · small accounts
- Incorporated
08
Similar companies in Cambridge
- NEOBE THERAPEUTICS LTDCambridge · inc. Jan 2021
- VIVAVACS LIMITEDCambridge · inc. Feb 2021
- STINGRAY BIO LIMITEDCambridge · inc. Dec 2020
- VIROLOGICA LIMITEDCambridge · inc. Dec 2020
- CENENTRY BIOSCIENCES LIMITEDCambridge · inc. Mar 2021
- 4BASEBIO DISCOVERY LIMITEDCambridge · inc. Oct 2020
All companies incorporated on 15 January 2021 · in Jan 2021.
09
Reminders for CAMBRIDGE NUCLEOMICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.